Mediphage Bioceuticals
Toronto
About Mediphage Bioceuticals
Mediphage Bioceuticals is a genetic medicine company focused on developing safe, effective, and personalized transgene delivery platforms for the delivery of genes into cells for gene therapy, cell engineering and gene editing. Our flagship technology, ministring DNA (msDNA) is the safest transgene delivery vector on the market that does not compromise effectiveness and can be produced at a fraction of the cost of competing solutions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.1M
- Funding stage: Seed
- Last round: Grant (Jan 2026)
- Website: mediphage.ca
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/mediphage-bioceuticals-40820 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.